<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Merck&#8217;s New Cholesterol Pill Has Mixed Results</title>
	<atom:link href="http://www.pharmalot.com/2008/03/mercks-new-cholesterol-pill-has-mixed-results/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/03/mercks-new-cholesterol-pill-has-mixed-results/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 22:46:18 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Doc</title>
		<link>http://www.pharmalot.com/2008/03/mercks-new-cholesterol-pill-has-mixed-results/#comment-238153</link>
		<dc:creator>Doc</dc:creator>
		<pubDate>Mon, 31 Mar 2008 16:47:01 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/mercks-new-cholesterol-pill-has-mixed-results/#comment-238153</guid>
		<description>Gosh imagine that, ENHANCE is a bomb for Merck, so now let's tweak our Cordaptive trial. These studies are not changed for any good reason, unless like the Crestor study, there is so much benefit it makes no sense to go on with the trial. Those Merck epidemiologists have sure been busy lately.</description>
		<content:encoded><![CDATA[<p>Gosh imagine that, ENHANCE is a bomb for Merck, so now let&#8217;s tweak our Cordaptive trial. These studies are not changed for any good reason, unless like the Crestor study, there is so much benefit it makes no sense to go on with the trial. Those Merck epidemiologists have sure been busy lately.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.147 seconds -->

